High potency and specific tumoricidal activity of HAS-stimulated lymphocytes induced by tumor antigen pulsed dendritic cells

张建芳,于文彬,徐修礼,刘宝瑞

2001-01-01

Abstract:Aim To induce high potency and specific tumoricidal immuneresponse in vitro by HAS-stimulated lymphocytes and dendritic cells. Methods Dendritic cells(DC) were derived from PBMC stimulated with GM-CSF and IL-4. DC were pulsed with soluble tumor antigen extracted from lung cancer cell line GLC-82 TNF-α and PGE2 were used to enhance antigen-presenting ability of DC. Nonadherant cells from the PBMC were cultured in the presence of HAS(named HASL).DC and HASL were cocultured for 4 hours on day 10 and the obtained cells were named DC-HASL. DC cocultured with lymphocytes were named DC-L. Cytotoxicity of HASL,DC-L and DC-HASL were determined by MTT assay. Phenotypes of DC and HASL were analyzed by FACS. Results Cytotoxic rates of DC-HASL to GLC-82 cells reached 100％ and the cytotoxic rates to other cancer cell lines A549, moser and MCF-7 were 94.2％ ,73.5％ and 71.2％ respectively; Cytotoxic rates of HASL and DC-L to the above four cell lines were 63％ ,48％ ,60％ ,45％ and 46.4％ ,42.1％ ,39％ ,25.6％ respectively. The percent of CD3＋ CD56＋ cells was increasing greatly after stimulated by HAS. Conclusion HASL can lyse tumor cells to a certain extent ,but there was no obvious specificity. DC-HASL can specifically lyse tumor antigen-bearing GLC-82 cell line and it's cytotoxicity to A549 cells increased distinctly. As compared with DC-HASL, DC-L has lower cytotoxicity and specificity, suggesting that specific effect cells for tumor immunotherapy can be prepared using DC and HASL,meanwhile, also providing the probability for tumor adoptive immunotherapy by homologous effect cells.